BRAF and neoplasm: The oncogenic BRAF can lead to immunomodulation and immune escape in melanoma, by i) the secretion of immunosuppressive cytokines in the microenvironment; ii) eliciting immune suppressive phenotype of the immune cells in the microenvironment; iii) modulating the MHC level in tumor cells [245].